BME100 f2015:Group6 8amL2
|BME 100 Fall 2015|| Home |
Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3
Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6
Course Logistics For Instructors
Wiki Editing Help
LAB 2 WRITE-UP
There is a significant difference between Inflammotin levels for each dosage amount with respect to each other, since the p-value for each of the comparisons is less than .05. We use an ANOVA because we are investigating differences among several groups.
There is no significant difference between Inflammotin levels with dosages of 0 mg and 10 mg of LPS in rats within the groups because there is a .86 p-value which is greater than the 0.05 p-value necessary to claim a significant difference. We use a t-test because we are investigating differences between two groups.
Based on the experiment with the use of rats, there is not a significant difference between the Inflammotin levels in the 0mg and 10mg LPS dosage groups. The LPS does not appear to be effective in increasing Inflammotin levels in the rats in this experiment. In the human study results, the inflammotin levels also get higher with the increase of dosage, but by greater amounts. In the human study results, while the increase in inflammotin levels is great between the 0mg and 5mg, once it gets to 10mg and 15mg of LPS, there is a much greater difference. We find that each dosage above 0mg is effective in raising Inflammotin levels, with effectiveness increasing with an increase in LPS dosage. Therefore, LPS in these dosage amounts appears to be more effective in humans than in rats. We find that each dosage results in a significant difference in Inflammotin levels with respect to the other dosages. When using the rats as test subjects, the standard error for rats is more when at the dosage of 0mg but less at the 10mg dosage. For the human standard error the error is larger at 10mg and 15mg than at 0mg and 5mg.